Assume costings for advanced clinical services are included in the estimated quarterly expenditure reported yesterday?
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Selects Advanced Clinical as CRO for Phase 3
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.67%
!
29.5¢

Ann: PAR Selects Advanced Clinical as CRO for Phase 3, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $116.8M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 29.5¢ | $7.359K | 24.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 22639 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 2295 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29211 | 0.295 |
5 | 98339 | 0.290 |
4 | 104197 | 0.285 |
18 | 254726 | 0.280 |
6 | 152655 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 2295 | 3 |
0.305 | 15906 | 2 |
0.310 | 16621 | 3 |
0.315 | 94295 | 4 |
0.320 | 127866 | 10 |
Last trade - 10.12am 23/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |